⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 1, 2022Drug SafetyOpen Access

Artificial Intelligence and Machine Learning for Safe Medicines

Andrew Bate Yuan Luo

View Full Paper

Ask AI

Bookmark

Share

Abstract

Authors' views on the role of artificial intelligence and machine learning in pharmacovigilance. (MP4 139807 kb).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bate et al. (2022) studied this question.

synapsesocial.com/papers/6a791a3cc284d7a4ba5ae589 https://doi.org/10.1007/s40264-022-01177-0

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Safety of medicines and vaccines – building next generation capabilityReview · 2021 · 20 citations
2Challenges to the Reproducibility of Machine Learning Models in Health CareReview · 2020 · 362 citations
3MIMIC-III, a freely accessible critical care databaseOriginal Research · 2016 · 8,017 citations
4Proactive vs Reactive Machine Learning in Health CareOriginal Research · 2022 · 24 citations
5A statistical methodology for drug–drug interaction surveillanceReview · 2008 · 204 citations

More from Drug Safety

EudraScore: Modification of the Vigi4Eudra-score for the Assessment of the Completeness of Adverse Drug Reaction Reports in EudraVigilanceWed,
Consumer Views on the Role of the Natural Health Products (NHPs) Industry in Pharmacovigilance for NHPs: A Qualitative Study in New ZealandFri,
Drug Brand Switching: A Regulatory PerspectiveThu,
The Value of Time-to-Onset for Signal Validation: Experience from the Reporting of COVID-19 Vaccines and Glomerular Diseases in VigiBaseThu,
A Text-Mining Algorithm for Identifying Drug Pairs Potentially Involved in Prescribing Cascades: Development and Internal Validation Within the Prescribing Inappropriateness Assessment (PINA) Digital ToolSat,